• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Gains Over 100 Points; Fed Leaves Interest Rates Unchanged

    11/1/23 2:33:23 PM ET
    $CLLS
    $IRIX
    $PATI
    $PAYC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $CLLS alert in real time by email

    U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision.

    The Dow traded up 0.40% to 33,185.41 while the NASDAQ rose 0.92% to 12,969.54. The S&P 500 also rose, gaining, 0.67% to 4,221.94.

    Check This Out: $2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

     

    Leading and Lagging Sectors

    Information technology shares jumped by 1.2% on Wednesday.

    In trading on Wednesday, materials shares fell by 0.6%.

     

    Top Headline

    The Federal Reserve opted to maintain interest rates at the range of 5.25% to 5.5% during its November meeting, as widely anticipated by the market.

     

    Equities Trading UP

    Cellectis S.A. (NASDAQ:CLLS) shares shot up 194% to $2.8335. Cellectis reported strategic collaboration and investment agreements with AstraZeneca. Cellectis also presented pre-clinical data on multi-armored allogeneic MUC1-CAR T-cells targeting triple-negative breast cancer at the Society for Immunotherapy of Cancer 38th Annual Meeting.

    Shares of Patriot Transportation Holding, Inc. (NASDAQ:PATI) got a boost, shooting 103% to $15.59. Patriot Transportation announced an agreement under which United Petroleum Transports will acquire all of the outstanding shares of Patriot common stock for $16.26 per share in cash.

    TG Therapeutics, Inc. (NASDAQ:TGTX) shares were also up, gaining 32% to $10.18 following third-quarter results.

     

    Equities Trading DOWN

    WeWork Inc. (NYSE:WE) shares dropped 51% to $1.1150 following reports that the company is nearing bankruptcy.

    Shares of IRIDEX Corporation (NASDAQ:IRIX) were down 38% to $2.0425. Iridex has withdrawn its previously announced annual guidance for 2023 and plans to provide additional information during its third-quarter earnings release based on the information available at that time.

    Paycom Software, Inc. (NYSE:PAYC) was down, falling 39% to $150.30. Paycom Software reported worse-than-expected third-quarter sales results and issued FY23 revenue guidance below estimates.

    Also Check This Out: Top 3 Consumer Stocks That Could Sink Your Portfolio In Q4

     

    Commodities

    In commodity news, oil traded down 0.1% to $80.91 while gold traded down 0.3% at $1,986.90.

    Silver traded down 0.5% to $22.835 on Wednesday while copper fell 0.1% to $3.6450.

     

    Euro zone

    European shares were higher today. The eurozone’s STOXX 600 gained 0.67%, London’s FTSE 100 rose 0.28% while Spain’s IBEX 35 Index rose 0.64% The German DAX gained 0.76% French CAC 40 climbed 0.68%, while Italy’s FTSE MIB Index jumped 0.88%.

    The S&P Global/CIPS UK manufacturing PMI was revised lower to 44.8 in October from the preliminary reading of 45.2, while Nationwide House Price Index fell by 3.3% year-over-year in October.

     

    Asia Pacific Markets

    Asian markets closed mixed on Wednesday, with Japan’s Nikkei 225 rising 2.41%, Hong Kong’s Hang Seng Index falling 0.06% and China’s Shanghai Composite Index gaining 0.14%. India’s S&P BSE Sensex, meanwhile, slipped around 0.4%.

    Retail sales in Hong Kong surged 10.1% year-over-year in September versus a 11% increase in the prior month. The S&P Global India manufacturing PMI fell to 55.5 in October from 57.5, while the Caixin China general manufacturing PMI declined to 49.5 in October from 50.6 in the previous month. The au Jibun Bank Japan manufacturing PMI was revised higher to 48.7 in October.

     

    Economics

    Private businesses in the U.S. added 113,000 workers in October, compared to market estimates of a 150,000 increase and versus a gain of 89,000 in the prior month.

    Construction spending in the U.S. increased by 0.4% month-over-month to an annual rate of $1,996.5 billion in September.

    The number of job openings rose by 56,000 from the prior month to 9.55 million in September.

    The S&P Global manufacturing PMI rose to 50.0 in October from 49.8 in September.

    The ISM Manufacturing PMI fell to 46.7 in October versus 49 in the prior month, compared to market expectations of 49.

    U.S. crude oil inventories increased by 0.774 million barrels in the week ending Oct. 27, 2023, compared to a 1.371 million rise in the prior period and versus market estimates of a 1.261 million increase.

    The Federal Reserve left the key interest rate unchanged at the range of 5.25% to 5.5% on Wednesday.

    Now Read This: These 3 Real Estate Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts

    Get the next $CLLS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLLS
    $IRIX
    $PATI
    $PAYC

    CompanyDatePrice TargetRatingAnalyst
    Paycom Software Inc.
    $PAYC
    2/12/2026$175.00 → $137.00Market Perform
    BMO Capital Markets
    Paycom Software Inc.
    $PAYC
    12/17/2025$195.00Buy
    BTIG Research
    TG Therapeutics Inc.
    $TGTX
    10/6/2025$60.00Buy
    H.C. Wainwright
    Paycom Software Inc.
    $PAYC
    9/26/2025$270.00Buy
    Guggenheim
    Paycom Software Inc.
    $PAYC
    9/22/2025$258.00Hold → Buy
    TD Cowen
    Paycom Software Inc.
    $PAYC
    8/14/2025$230.00Neutral
    Cantor Fitzgerald
    Paycom Software Inc.
    $PAYC
    8/7/2025$244.00 → $258.00Market Perform
    BMO Capital Markets
    TG Therapeutics Inc.
    $TGTX
    7/10/2025$37.00Neutral
    Goldman
    More analyst ratings

    $CLLS
    $IRIX
    $PATI
    $PAYC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (ORIG-1) with active ingredient UBLITUXIMAB has changed to 'Approval' on 12/28/2022. Application Category: BLA, Application Number: 761238, Application Classification:

    12/28/22 12:54:09 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for UKONIQ

    Submission status for TG THERAPEUTICS INC's drug UKONIQ (ORIG-1) with active ingredient UMBRALISIB TOSYLATE has changed to 'Approval' on 02/05/2021. Application Category: NDA, Application Number: 213176, Application Classification: Type 1 - New Molecular Entity

    2/9/21 12:05:59 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Foster Robert D. covered exercise/tax liability with 3,515 shares and was granted 9,589 shares, increasing direct ownership by 44% to 19,852 units (SEC Form 4)

    4 - Paycom Software, Inc. (0001590955) (Issuer)

    2/12/26 4:08:10 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    CEO, President and Chairman Richison Chad R. covered exercise/tax liability with 18,921 shares and was granted 43,148 shares, increasing direct ownership by 0.91% to 2,690,594 units (SEC Form 4)

    4 - Paycom Software, Inc. (0001590955) (Issuer)

    2/12/26 4:07:10 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Chief Operating Officer Peck Randall was granted 8,390 shares and covered exercise/tax liability with 3,680 shares, increasing direct ownership by 11% to 48,215 units (SEC Form 4)

    4 - Paycom Software, Inc. (0001590955) (Issuer)

    2/12/26 4:05:47 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Paycom Software with a new price target

    BMO Capital Markets reiterated coverage of Paycom Software with a rating of Market Perform and set a new price target of $137.00 from $175.00 previously

    2/12/26 6:46:23 AM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    BTIG Research resumed coverage on Paycom Software with a new price target

    BTIG Research resumed coverage of Paycom Software with a rating of Buy and set a new price target of $195.00

    12/17/25 9:25:02 AM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    H.C. Wainwright resumed coverage on TG Therapeutics with a new price target

    H.C. Wainwright resumed coverage of TG Therapeutics with a rating of Buy and set a new price target of $60.00

    10/6/25 8:31:23 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New Study Finds Paycom's IWant Has Delivered Significant ROI

    Paycom Software, Inc. (NYSE:PAYC) ("Paycom"), a leading provider of comprehensive, cloud-based human capital management software, revealed findings from a commissioned study conducted by Forrester Consulting examining the projected benefits of IWant™, the industry's first command-driven AI engine in a single database. According to the Forrester study, a composite organization representative of interviewed Paycom clients received a projected three-year return on investment (ROI) of up to 431%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212698207/en/New study finds Paycom's IWant has delivered significant ROI Recognized as

    2/12/26 9:15:00 AM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Paycom Software, Inc. Reports Fourth Quarter and Year-End 2025 Results

    Full Year Revenues of $2,052 million, up 9% year-over-year Full Year GAAP Net Income of $453 million, representing 22% of total revenues, or $8.08 per diluted share Full Year Non-GAAP Net Income of $519 million, or $9.24 per diluted share Full Year Adjusted EBITDA of $882 million, representing 43% of total revenues Paycom Software, Inc. ("Paycom," "we" and "our") (NYSE:PAYC), a leading provider of comprehensive, cloud-based human capital management software, today announced its financial results for the quarter and year ended December 31, 2025. "We delivered strong results in 2025, exceeding our strategic and financial goals for the year by driving full solution automation and str

    2/11/26 4:05:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Paycom Announces Quarterly Cash Dividend

    Paycom Software, Inc. ("Paycom") (NYSE:PAYC), a leading provider of comprehensive, cloud-based human capital management software, announced today that its Board of Directors declared a cash dividend in the amount of $0.375 per share of common stock, to be paid on March 23, 2026, to all stockholders of record as of the close of business on March 9, 2026. About Paycom Paycom Software, Inc. (NYSE:PAYC) simplifies business and employees' lives through automated, command-driven HR and payroll technology that revolutionizes data access. From hire to retire, Paycom's employee-first technology leverages AI and full-solution automation to streamline processes and drive efficiencies in a truly si

    2/10/26 5:00:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    $CLLS
    $IRIX
    $PATI
    $PAYC
    SEC Filings

    View All

    Paycom Software Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Paycom Software, Inc. (0001590955) (Filer)

    2/11/26 4:10:28 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Paycom Software Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Paycom Software, Inc. (0001590955) (Filer)

    2/10/26 5:10:24 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    TG Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - TG THERAPEUTICS, INC. (0001001316) (Filer)

    1/13/26 4:27:48 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Dizon Romeo R bought $2,145 worth of shares (1,500 units at $1.43), increasing direct ownership by 1% to 117,690 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    2/12/26 10:05:32 AM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chief Financial Officer Dizon Romeo R bought $1,460 worth of shares (1,000 units at $1.46), increasing direct ownership by 0.87% to 116,190 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    2/10/26 3:19:41 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chief Financial Officer Dizon Romeo R bought $3,450 worth of shares (2,500 units at $1.38), increasing direct ownership by 2% to 115,190 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    2/3/26 6:21:19 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Leadership Updates

    Live Leadership Updates

    View All

    Paycom promotes Shane Hadlock to lead IT; appoints Rachael Gannon to chief automation officer

    Brad Smith named senior technical strategist Paycom Software, Inc. (NYSE:PAYC) ("Paycom"), a leading provider of comprehensive, cloud-based human capital management software, today announced the expanded role of Shane Hadlock as Paycom's chief client officer and chief technology officer and the promotion of Rachael Gannon to chief automation officer, effective Aug. 18. Brad Smith has been named the company's senior technical strategist and will continue reporting to CEO Chad Richison. As chief technology officer, Hadlock will oversee Paycom's IT department, while maintaining his chief client officer role and leadership of Paycom's client service groups. "Shane's exceptional client-cen

    8/18/25 4:05:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer

    EMERYVILLE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent DNA-encoded libraries and AI tools, today announced the appointment of Simon Harnest, MSc, BSc, as Chief Financial Officer. This key addition comes at a pivotal moment for Totus as the company prepares to advance its clinical-stage program following encouraging results from its Phase 1 study of TOS-358, a covalent PI3Kα inhibitor. "The addition of Simon, with over 15 years' experience in private capital markets strategy and IPO processes, comes at the right time for Totus as we advance our clinical-stage and discovery programs," said

    1/28/25 8:00:00 AM ET
    $CBUS
    $CLLS
    $MGX
    Agricultural Chemicals
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Joe Binz Appointed to Paycom's Board of Directors

    Paycom Software, Inc. (NYSE:PAYC) ("Paycom"), a leading provider of comprehensive, cloud-based human capital management software, today announced the appointment of Joe Binz to Paycom's board of directors, effective Dec. 10, 2024. Binz currently serves as chief financial officer at Atlassian, where he is responsible for its global finance organization and oversees the company's accounting, finance, internal audit, investor relations, tax, treasury and procurement teams. He has more than 30 years of financial leadership experience in the technology industry. Prior to joining Atlassian, Binz held management roles at Microsoft, where he led the company's finance functions and guided its bu

    12/12/24 4:05:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Financials

    Live finance-specific insights

    View All

    Paycom Software, Inc. Reports Fourth Quarter and Year-End 2025 Results

    Full Year Revenues of $2,052 million, up 9% year-over-year Full Year GAAP Net Income of $453 million, representing 22% of total revenues, or $8.08 per diluted share Full Year Non-GAAP Net Income of $519 million, or $9.24 per diluted share Full Year Adjusted EBITDA of $882 million, representing 43% of total revenues Paycom Software, Inc. ("Paycom," "we" and "our") (NYSE:PAYC), a leading provider of comprehensive, cloud-based human capital management software, today announced its financial results for the quarter and year ended December 31, 2025. "We delivered strong results in 2025, exceeding our strategic and financial goals for the year by driving full solution automation and str

    2/11/26 4:05:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Paycom Announces Quarterly Cash Dividend

    Paycom Software, Inc. ("Paycom") (NYSE:PAYC), a leading provider of comprehensive, cloud-based human capital management software, announced today that its Board of Directors declared a cash dividend in the amount of $0.375 per share of common stock, to be paid on March 23, 2026, to all stockholders of record as of the close of business on March 9, 2026. About Paycom Paycom Software, Inc. (NYSE:PAYC) simplifies business and employees' lives through automated, command-driven HR and payroll technology that revolutionizes data access. From hire to retire, Paycom's employee-first technology leverages AI and full-solution automation to streamline processes and drive efficiencies in a truly si

    2/10/26 5:00:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Paycom Software, Inc. Announces Fourth Quarter and Year-End 2025 Earnings Release Date and Conference Call

    Paycom Software, Inc. ("Paycom") (NYSE:PAYC), a leading provider of comprehensive, cloud-based human capital management software, will release its results for the fourth quarter and year-ended Dec. 31, 2025, after the market closes on Feb. 11. Paycom will also hold a conference call to discuss results at 5 p.m. (Eastern) that day. Dial-in #: +1 (833) 470-1428 Intl. Dial-In #: +1 (646) 844-6383 Access Code: 829388 Replay #: +1 (866) 813-9403 Intl. Replay #: +1 (929) 458-6194 Replay Access Code: 951764 The conference call will also be webcast at investors.paycom.com. For those unable

    1/21/26 4:05:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Paycom Software Inc.

    SC 13D/A - Paycom Software, Inc. (0001590955) (Subject)

    12/13/24 7:06:11 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by TG Therapeutics Inc.

    SC 13G/A - TG THERAPEUTICS, INC. (0001001316) (Subject)

    11/14/24 7:45:34 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Paycom Software Inc.

    SC 13G - Paycom Software, Inc. (0001590955) (Subject)

    11/14/24 4:07:41 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology